1. Home
  2. STRR vs KZIA Comparison

STRR vs KZIA Comparison

Compare STRR & KZIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STRR
  • KZIA
  • Stock Information
  • Founded
  • STRR 1985
  • KZIA 1994
  • Country
  • STRR United States
  • KZIA Australia
  • Employees
  • STRR N/A
  • KZIA N/A
  • Industry
  • STRR Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • KZIA Biotechnology: Pharmaceutical Preparations
  • Sector
  • STRR Health Care
  • KZIA Health Care
  • Exchange
  • STRR Nasdaq
  • KZIA Nasdaq
  • Market Cap
  • STRR 6.3M
  • KZIA 5.1M
  • IPO Year
  • STRR N/A
  • KZIA 1999
  • Fundamental
  • Price
  • STRR $2.13
  • KZIA $5.65
  • Analyst Decision
  • STRR Strong Buy
  • KZIA Strong Buy
  • Analyst Count
  • STRR 1
  • KZIA 2
  • Target Price
  • STRR $5.00
  • KZIA $57.50
  • AVG Volume (30 Days)
  • STRR 61.6K
  • KZIA 24.0K
  • Earning Date
  • STRR 05-14-2025
  • KZIA 06-17-2025
  • Dividend Yield
  • STRR N/A
  • KZIA N/A
  • EPS Growth
  • STRR N/A
  • KZIA N/A
  • EPS
  • STRR N/A
  • KZIA N/A
  • Revenue
  • STRR $57,165,000.00
  • KZIA $1,655,324.00
  • Revenue This Year
  • STRR $33.64
  • KZIA N/A
  • Revenue Next Year
  • STRR $22.87
  • KZIA N/A
  • P/E Ratio
  • STRR N/A
  • KZIA N/A
  • Revenue Growth
  • STRR 34.33
  • KZIA 248000.00
  • 52 Week Low
  • STRR $1.72
  • KZIA $2.86
  • 52 Week High
  • STRR $5.35
  • KZIA $79.00
  • Technical
  • Relative Strength Index (RSI)
  • STRR 47.17
  • KZIA 78.10
  • Support Level
  • STRR $2.16
  • KZIA $3.54
  • Resistance Level
  • STRR $2.75
  • KZIA $4.00
  • Average True Range (ATR)
  • STRR 0.24
  • KZIA 0.50
  • MACD
  • STRR -0.00
  • KZIA 0.25
  • Stochastic Oscillator
  • STRR 32.80
  • KZIA 86.07

About STRR Star Equity Holdings Inc.

Star Equity Holdings Inc is a multi-industry diversified holding company. It operates in two segments: Building Solutions segment, through KBS, EBGL and TT, it services residential and commercial construction projects by manufacturing modular housing units, structural wall panels, permanent wood foundation systems, other engineered wood products, and supply general contractors with building materials; and Investments segment, which holds corporate-owned real estate, currently includes one manufacturing facility and the equipment for another manufacturing facility in Maine that it leases back to KBS and its manufacturing facility in Wisconsin that it leases back to TT. The company derives maximum revenue from Building Solutions Segment.

About KZIA Kazia Therapeutics Limited

Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors. Maximum of revenue is earned from South Korea.

Share on Social Networks: